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Abstract
The role of the pore-forming Staphylococcus aureus toxin Panton-Valentine leukocidin (PVL) in severe necrotizing diseases is
debated due to conflicting data from epidemiological studies of community-associated methicillin-resistant S. aureus (CA-
MRSA) infections and various murine disease-models. In this study, we used neutrophils isolated from different species to
evaluate the cytotoxic effect of PVL in comparison to other staphylococcal cytolytic components. Furthermore, to study the
impact of PVL we expressed it heterologously in a non-virulent staphylococcal species and examined pvl-positive and pvl-
negative clinical isolates as well as the strain USA300 and its pvl-negative mutant. We demonstrate that PVL induces rapid
activation and cell death in human and rabbit neutrophils, but not in murine or simian cells. By contrast, the phenol-soluble
modulins (PSMs), a newly identified group of cytolytic staphylococcal components, lack species-specificity. In general, after
phagocytosis of bacteria different pvl-positive and pvl-negative staphylococcal strains, expressing a variety of other
virulence factors (such as surface proteins), induced cell death in neutrophils, which is most likely associated with the
physiological clearing function of these cells. However, the release of PVL by staphylococcal strains caused rapid and
premature cell death, which is different from the physiological (and programmed) cell death of neutrophils following
phagocytosis and degradation of virulent bacteria. Taken together, our results question the value of infection-models in
mice and non-human primates to elucidate the impact of PVL. Our data clearly demonstrate that PVL acts differentially on
neutrophils of various species and suggests that PVL has an important cytotoxic role in human neutrophils, which has major
implications for the pathogenesis of CA-MRSA infections.
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Introduction
Staphylococcus aureus is an important human pathogen that can
cause serious diseases [1]. In the last few years, there was a
dramatic increase in the incidence of community-associated
methicillin-resistant S. aureus (CA-MRSA) infections in otherwise
healthy individuals and resistance to multiple antibiotic classes
largely limits therapeutic options. Especially the MRSA strain
USA300 has widely spread within the United States and has
become the cause of more unusually severe diseases, including
necrotizing pneumonia, skin infections, osteomyelitis and necro-
tizing fasciitis [2,3]. Necrotizing pneumonia seems to be a specific
disease entity and often follows infection with influenza virus [4,5].
To combat these life-threatening infections, there is a need to
better understand the bacteria-host interaction and virulence
factors involved.
Clinical studies propose the exotoxin Panton-Valentine leuko-
cidin (PVL) as a crucial virulence factor in necrotizing diseases
[4,6]. PVL is a two component pore-forming toxin, which mainly
acts on neutrophils [7]. It is expressed by only a small percentage
of S. aureus wild-type isolates (2–3%) [8], but it is highly prevalent
in S. aureus strains isolated from necrotizing infections [4,6].
However, several studies that used a diversity of animal models
have created conflicting results concerning the role of PVL. One
study, applying a mouse acute pneumonia model, suggests PVL as
major virulence factor [9]. By contrast, other groups fail to detect a
pathogenic function of PVL in murine lung and skin infections and
in cell culture experiments, but demonstrate a predominant role of
a-hemolysin (a-toxin) and a possible relevance of the bacterial
surface protein A (Spa) [10–12]. Both factors are expressed at high
prevalence among clinical isolates and are considered to
contribute to various disease entities [1,13,14]. Yet, when a rabbit
bacteremia model was used, a transient effect of PVL in the acute
phase of infection could be demonstrated [15]. Furthermore, a
recent study identified a group of S. aureus peptides, the phenol-
soluble modulins (PSMs), with strong cytolytic activity on human
neutrophils. As PSMs are released at high concentrations by CA-
MRSA strains and contribute to disease development in murine
models, the authors propose that PSMs account for the enhanced
virulence of CA-MRSA [16].
However, there is some evidence that the actions of S. aureus
toxins can be strongly dependent on the animal species used,
which should be analysed in detail to better interpret disease-
models. In particular, the host cell response to PVL may be
PLoS Pathogens | www.plospathogens.org 1 January 2010 | Volume 6 | Issue 1 | e1000715species-specific [17], whereas the effects of other staphylococcal
factors, such as PSMs, might be species-independent. In this study,
we used polymorphonuclear cells (neutrophils) from different
species including humans, mice, rabbits and monkeys to test the
effect of several virulence factors. As neutrophils are the major
defending cells against bacterial invasion, their excessive cell death
most likely largely promotes disease development.
Results
The effect of purified S. aureus virulence factors on
neutrophils from different species
First, we challenged human neutrophils with purified S. aureus
components, including PVL, a-toxin, protein A and PSMs. For
PVL, doses$40 ng/ml (0.04 mg/ml) were sufficient to induce cell
damage (Figure 1A). Cell death occurred rapidly, within 1 h, and
most likely due to necrosis, as we could not detect characteristic
apoptotic features (Figure S2) [18]. In contrast to PVL, a-toxin or
protein A did not cause cell death, even when applied at high
concentrations, which have pro-inflammatory or cytotoxic effects
in other cell types [19,20]. As recently published [16], three
different forms of S. aureus PSMs (PSMa1, PSMa2, PSMa3) were
able to provoke cell-lysis. However, cell death induction required
relatively high doses of PSMs ($40 mg/ml) in comparison to PVL
($40 ng/ml) (Figure 1A). In previous studies, the impact of PVL
was mainly tested on human or rabbit neutrophils, as cells from
both species were reported to be susceptible to PVL [17]. In line
with published data, we found similar responses of human and
rabbit neutrophils to low doses of PVL (Figure 1B). The action of
PVL appears to be tightly restricted to these species, as neutrophils
isolated from Java monkeys (Macaca fascicularis, cynomolgus), the most
commonly used non-human primate in biomedical research, were
not killed in response to PVL (Figure 1C). In recent reports,
models of severe staphylococcal infections were mainly performed
in the murine strains BALB/c or C57/BL6 [9,10]. However,
murine neutrophils from both strains were largely resistant to PVL
(Figure 1D, E), irrespective of their maturation and inflammatory
state (Figure S3).
In contrast to PVL, all PSM-types tested (PSMa1–3) lysed
neutrophils from different species at concentrations$40 mg/ml,
indicating that the actions of PSMs apparently lack species-
specificity (Figure 1A–E). Further on, we detected additional
differences between PVL- and PSM-induced cell death. Incuba-
tion with PVL caused changes in cell morphology, including
rounding and swelling of cells and nuclei (Figure 2A, 2B), which
persisted for several hours (data not shown). By contrast, PSM-
stimulated cells were rapidly destroyed without characteristic
changes in morphology (Figure 2A). In PVL-treated neutrophils,
an oxidative burst reaction (Figure 2C) and pro-inflammatory
activation (Figure S4) accompanied cell death induction, whereas
incubation with PSMs did not cause an oxidative burst (Figure 2C).
These results point to completely different mechanisms of action
provoked by the S. aureus cytotoxic components PVL and PSMs.
The effect of live bacteria, which differ in virulence factor
expression, on human neutrophils
To investigate the impact of defined virulence factor expression
we transformed S. carnosus TM300 with a plasmid encoding the
genes for PVL, a-toxin, protein A (Spa) or PSMs, respectively
(Table 1). Using live bacteria with these constructs revealed that
the expression of PVL most efficiently induced neutrophils cell
death (Figure 3A). The effect of TM300+PVL was comparable to
the cytotoxic potential of clonally independent MRSA (ST239)
and MSSA (6850) strains (Figure 3B) and of pvl-positive clinical
isolates, which were recovered from severe invasive (including
necrotizing pneumonia) diseases (Figure 3C). However, cytotox-
icity was not restricted to PVL-expressing strains, as live bacteria
of some pvl-negative isolates compromised cell viability to a similar
extent (Figure 3D). Moreover, we could not detect differences
between strain USA300 and the corresponding mutant
USA300DPVL (Figure 3B), indicating that the presence of the
pvl-gene does not necessarily contribute to neutrophils cell death
following phagocytosis of bacteria. We also failed to block the
cytotoxic effect of USA300 by the use of antibodies against PVL
(Figure S5). These findings indicate that other staphylococcal
factors can also induce cell death, which might mask the cytotoxic
function of PVL. However, the expression of a-toxin and PSMs in
TM300 had no effect on neutrophils. Apparently, PSMs need to
accumulate to lyse neutrophils, as the corresponding bacterial
supernatants, which contained PSMs, were cytolytic (Figure S6)
[16].
Besides PVL, the expression of protein A moderately decreased
the number of intact cells (Figure 3A). This is further demonstrated
by using strain Cowan I, which is a high producer of protein A,
whereas two isogenic mutants (Dspa) were much less cytotoxic
(Figure 3E). Although protein A is known to be a cell wall-
anchored protein with an anti-phagocytic effect [14], we observed
an increased rate of cell death. In our experiments, the action of
protein A was dependent on the expression by bacteria, which
exhibit protein A on the bacterial surface. This phenomenon was
not specific for protein A, as the expression of another wall-
associated protein, namely fibronectin-binding protein A (FnBPA),
also reduced the number of intact neutrophils (Figure 3F). In
general, phagocytosis of pathogens triggers mechanisms to kill
ingested bacteria. Further on, it has been shown that phagocytosis
significantly accelerates neutrophils apoptosis, which appears to
contribute to the resolution of the inflammatory response [21,22].
These processes promote healthy resolution and could be an
explanation for the enhanced rate of cell death caused by bacteria
holding virulent surface proteins. This assumption is further
Author Summary
Staphylococcus aureus can cause serious diseases, includ-
ing necrotizing pneumonia, which often affects young
immunocompetent patients and has a high lethality rate.
Several clinical studies demonstrated a clear association
between this form of pneumonia and S. aureus strains
carrying the gene for the pore-forming toxin Panton-
Valentine leukocidin (PVL). However, laboratory work,
which mainly used murine disease models, has created
very contrasting results and often fails to show a
pathogenic role for PVL. In this study, we demonstrate
that the expression of PVL by staphylococcal strains
confers strong and rapid cytotoxic activity against
neutrophils. However, this action was basically restricted
to human cells and could not be reproduced in murine or
Java monkeys’ cells. These results indicate that infection-
models in mice and in non-human primates fail to replicate
the pathogenic activity of PVL seen in human cells. Our
data with human neutrophils clearly show that PVL has a
major cytotoxic effect, as the release of PVL by staphylo-
coccal strains caused rapid and premature cell death,
which is different from the physiological (and pro-
grammed) cell death of neutrophils following phagocyto-
sis and degradation of virulent bacteria. These results have
important implications especially for infections with CA-
MRSA strains, which often carry the gene for PVL and have
spread widely in the community.
PVL Kills Human Neutrophils
PLoS Pathogens | www.plospathogens.org 2 January 2010 | Volume 6 | Issue 1 | e1000715Figure 1. The cytolytic effect of purified S.aureus virulence factors on neutrophils from different species. Neutrophils from different
species, including human (A), rabbit (B), Java monkey (C), BALB/c mice (D), C57/BL6 mice (E) were freshly isolated and 1610
6 0.5 ml
21 cells were
incubated with increasing doses of PVL, a-toxin, protein A or PSMs (PSMa1, PSMa2, PSMa3), respectively. PVL: 0.02–0.2 mg/ml (0.5–5 nM); a-toxin: 5,
10 mg/ml (150, 300 nM); protein A: 10, 100 mg/ml (0.238, 2.38 mM); PSMs: 10–60 mg/ml (4–24 mM). Neutrophils were stimulated for 1 h and then cells
were washed, stained with annexin V and propidium iodide (taking another hour) and then cell death was measured by flow cytometry. The values
represent the mean 6 SEM of at least three independent experiments. * P#0.05, ** P#0.01, *** P#0.001 (independent t-test comparing the rate of
intact cells between control and stimulated cells). Taking of blood samples from humans and animals were approved by the local ethics committee.
doi:10.1371/journal.ppat.1000715.g001
PVL Kills Human Neutrophils
PLoS Pathogens | www.plospathogens.org 3 January 2010 | Volume 6 | Issue 1 | e1000715Figure 2. Differences between PVL- and PSMs-induced cell death. Human neutrophils were freshly isolated and stimulated with
staphylococcal components as described in figure 1. Neutrophils were stimulated for 1 h with PVL (80 ng/ml) or PSMs (60 mg/ml) and cells were
analyzed by light microscopy with a live cell imaging system (A). Neutrophils were stimulated for 1 h with PVL (40 ng/ml) and processed for electron
microscopy (B). Cells were stimulated for 10 min and an oxidative burst reaction was determined by a burst-test (Orpegen Pharma). The values
represent the mean 6 SEM of at least three independent experiments. * P#0.05, ** P#0.01, *** P#0.001 (independent t-test comparing the rate of
burst reaction between control and stimulated cells; C).
doi:10.1371/journal.ppat.1000715.g002
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PLoS Pathogens | www.plospathogens.org 5 January 2010 | Volume 6 | Issue 1 | e1000715confirmed by apoptotic features detected in neutrophils (Figure S7,
annexin V-positive cells).
However, bacterial toxins, such as PVL and PSMs, could
interfere with the physiological functions of neutrophils, by rapidly
and prematurely killing cells. To investigate this possibility we
analysed neutrophils cell death in a time-dependent manner.
Challenge with PVL ($40 ng/ml) induced cell death within the
first 20 min (Figure 4A), whereas incubation of neutrophils with
live bacteria resulted in a much slower rate of death induction
(within 2–3 h), which is most likely associated with the neutrophils
physiological function [21]. Using PVL-expressing (USA300) or
non PVL-expressing (ST239, 6850) strains did not reveal any
differences (Figure 4B).
The cytotoxic effect of bacterial culture supernatants is
dependent on PVL expression
PVL is a bacterial exotoxin, which is rapidly released and could
act on cells at the infection sites. To mimic this situation, we
stimulated neutrophils with sterile-filtered bacterial supernatants
from overnight cultures. Culture media from strain TM300+PVL
induced rapid cell death within 20 min, whereas supernatants
from the control strain TM300 did not affect cell integrity. Further
on, comparing supernatants from the wild-type strain USA300
with supernatants from the corresponding knock-out mutant
USA300DPVL revealed that culture media from the PVL-deletion
strain had a much reduced ability to induce cell death, as the
majority of cells remained intact (Figure 5A). The impact of PVL
release was further strengthened by testing clinical isolates.
Supernatants from four out of six pvl-positive strains, recovered
from severe (including necrotizing) diseases, had a much higher
cytotoxic activity than supernatants from pvl-negative strains (also
recovered from severe invasive diseases). It is of particular
importance, that PVL secretion of the strains (measured by
Western blot in the bacterial supernatants; Figure S1C) clearly
corresponded to the cytotoxic activity in all cases (Figure 5B).
Discussion
The role of PVL in severe CA-MRSA infections is debated due
to conflicting data from epidemiological studies, in vitro cell culture
experiments, and different animal disease models [9,10,12,23]. As
PVL was found in almost all MRSA strains that cause CA-MRSA
infections, such as necrotizing pneumonia, skin- and soft tissue
infections, it was assumed to be a crucial virulence factor [4,6].
These disease entities are characterized by massive tissue necrosis
and leukopenia, which has been linked to the ability of PVL to kill
neutrophils, the primary defending cells against invading bacteria.
However, different disease models in mice, in which USA300 and
the corresponding knock-out mutant were used, failed to detect a
pathogenic function for PVL [10,12]. In line with these data, we
found that murine neutrophils, isolated from different commonly
used mice strains, were quite insensitive to PVL. Neutrophils from
Java monkeys, a species much more closely related to humans,
were not affected by PVL. The reason for the differential
sensitivity of cells from various species is completely unknown,
but receptors/signal transduction pathways, which are confined to
certain species, might be involved. By contrast, all PSM-types
tested lysed neutrophils from different species equally efficient and
induced membrane damaging effects [16]. Since murine and
simian cells are largely resistant to PVL, PSMs might play a more
dominant role in S. aureus infections in mice or non-human
primates than in humans, especially when high S. aureus inocula
are needed to cause diseases. Our data strongly suggest that
animal models using mice or non-human primates do not correctly
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PVL Kills Human Neutrophils
PLoS Pathogens | www.plospathogens.org 6 January 2010 | Volume 6 | Issue 1 | e1000715Figure 3. The impact of PVL expression on human neutrophil survival. Human neutrophils were freshly isolated and 1610
6 0.5 ml
21 cells
were incubated with live bacteria, which were grown in overnight cultures and used for stimulating cells at an multiplicity of infection (MOI 10–200)
as indicated. In these experiments we used heterologous expression strains of TM300 and Cowan I (A, E, F), the wild-type strain USA300 and its
knock-out mutant USA300DPVL (B) and pvl-positive (C) and pvl-negative (D) clinical isolates from invasive diseases. After 1 h of incubation with
bacteria the cells were washed, stained with annexin V and propidium iodide (taking another hour) and then cell death was measured by flow
cytometry. The values represent the mean 6 SEM of at least three independent experiments.
doi:10.1371/journal.ppat.1000715.g003
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PLoS Pathogens | www.plospathogens.org 7 January 2010 | Volume 6 | Issue 1 | e1000715replicate S. aureus diseases in humans, at least if the role of PVL is
elucidated. As neutrophils from rabbits are much more susceptible
to PVL, this species is most likely more appropriate to study the
function of PVL in necrotizing diseases.
Very recently, a rabbit bacteremia model has been published,
which describes a modest and transient effect of PVL in the acute
phase of infection [15]. However, this type of infection might
not show the full pathogenicity of PVL expression, as during
bacteremia staphylococci are directly exposed to cells of the
immune system. In our experiments, we could not detect
differences in virulence between PVL-expressing and pvl-negative
(knock-out mutants or wild-type isolates) strains, when live bacteria
were directly phagocytized by neutrophils. This is in line with
other published data, demonstrating that disruption or absence of
the pvl-gene in S. aureus wild-type isolates (including USA300) did
not alter their capacity to induce neutrophils cell death [12,24].
Nevertheless, as cell death of neutrophils is part of the
physiological immune response following phagocytosis of bacteria
[21,22] and as S. aureus wild-type isolates express a wide variety of
factors promoting this process (e.g. diverse surface proteins) [1],
the effect of secreted PVL on human neutrophils might be masked
in this model. Furthermore, it is reasonable to suspect that PVL is
not (highly) expressed, when staphylococci are instantly phagocy-
tized by neutrophils, as toxic virulence factors were found to be
down-regulated after internalization of bacteria [25]. Like other
toxins, PVL is mainly expressed in the post-exponential bacterial
growth phase [26], which is most likely reached in encapsulated
infection foci, e.g. folliculitis, abscesses, tissue necrosis. Only
recently, high expression of PVL was found directly in clinical
samples from cutaneous abscesses of invasive CA-MRSA infec-
tions [27]. Here, PVL most likely accumulates and can also exert
systemic pathogenic actions upon entering the bloodstream. In
human neutrophils, low doses of PVL were sufficient to cause cell
death, which correspond to amounts produced by clinical CA-
MRSA strains [28]. Granted that the action of PVL involves yet
unknown host receptors/signal transduction pathways, PVL might
interfere with various functions of susceptible cells. Furthermore, it
is reasonable to speculate that host organisms can become even
more vulnerable against PVL, e.g. following an infection with
influenza virus. Additional studies on human cells and in
susceptible animal models (rabbits) will be necessary to clarify
these possibilities and to better define the functions of PVL in
staphylococcal infections.
Taken together, our results clearly demonstrate that PVL is a
strong cytotoxic factor for human neutrophils, which can play an
important role in CA-MRSA infections. Our results do not
contradict previously published work, as we could not find an
effect of PVL on murine neutrophils or when bacteria were
Figure 4. Time-dependent effect of purified PVL vs. live bacteria on neutrophil cell death induction. Human neutrophils were freshly
isolated and 1610
6 0.5 ml
21 cells were stimulated with purified PVL (A) or with live bacteria of wild-type strains at an MOI of 100 (B). Cell death was
determined every 15 min. For this, cells were washed, rapidly (for 5 min) stained with PI and cell death was instantly determined by flow cytometry.
The values represent the mean 6 SEM of at least three independent experiments.
doi:10.1371/journal.ppat.1000715.g004
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PLoS Pathogens | www.plospathogens.org 8 January 2010 | Volume 6 | Issue 1 | e1000715directly phagocytised by neutrophils. However, under certain
pathogenic conditions, such as necrosis and abscesses, which are
characteristic for severe invasive S. aureus diseases, PVL could exert
its function as a cytotoxic exotoxin in susceptible organisms. The
premature cell death of neutrophils may be extremely relevant in
the virulence of CA-MRSA. As neutrophils are the major defense
against invading bacteria, their excessive cell death most likely
largely compromises the host’s immune system. Furthermore,
uncontrolled neutrophils cell damage discharges many pro-
inflammatory components within the host tissue, which could
also essentially promote disease development. These results are
important for ongoing efforts to find therapeutics against S. aureus
infections. Due to the rapid spread of CA-MRSA strains and
situations, which favour S. aureus infections at a large scale, e.g.
epidemic of influenza, there is an urgent need for efficient
preventive and therapeutic strategies.
Materials and Methods
Ethics statement
Taking of blood samples from humans and animals and
cell isolation were conducted with approval of the local ethics
Figure 5. The cytotoxic effect of bacterial culture supernatants is dependent on PVL expression. Human neutrophils were freshly
isolated and 1610
6 0.5 ml
21 cells were incubated with bacterial supernatants, which were prepared from overnight cultures of different strains and
used for stimulating cells (10%). In these experiments we used bacterial supernatants of the heterologous expression strain TM300+PVL and of the
wild-type strain USA300 and its knock-out mutant USA300DPVL (A); furthermore we used bacterial supernatants of pvl-positive and pvl-negative
clinical isolates from invasive diseases (B). The presence of the pvl-gene in the indicated strains and the amount of PVL production in the bacterial
supernatants is given semi-quantitatively as listed in table 1 and demonstrated in Figure S1C. After 30 min of incubation of the cells with bacterial
supernatants, cells were washed, rapidly (for 5 min) stained with PI and cell death was instantly determined by flow cytometry. The values represent
the mean 6 SEM of at least three independent experiments. *** P#0.001 (independent t-test comparing the rate of intact cells after stimulation with
supernatants of USA300 and USA300DPVL).
doi:10.1371/journal.ppat.1000715.g005
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und der Medizinischen Fakulta ¨t der Westfa ¨lischen Wilhelms-
Universita ¨t Mu ¨nster). Human blood samples were taken from
healthy blood donors, who provided written informed consent for
the collection of samples and subsequent neutrophil isolation and
analysis. All animals were handled in strict accordance with good
animal practice and animal keeping and taking of blood samples
were supervised by the veterinary office of Mu ¨nster (Veterina ¨ramt
der Stadt Mu ¨nster).
Bacterial strains and cultures
Bacterial strains used in this study are listed in table 1. They
were all characterized for presence of genes encoding PVL and
a-toxin by PCR. Gene expression was investigated by Western
blots for PVL (Figure S1B+C) or by hemolysis on sheep blood agar
plates (sign for a-toxin production). For cell culture and animal
experiments with live staphylococci, bacteria were grown over-
night at 37uCi nM u ¨ller-Hinton medium (MH, containing
antibiotics/xylose, if mutants are used) without shaking. Bacteria
were washed in PBS and resuspended in PBS with 1% HSA.
Neutrophils were incubated with bacterial suspensions, resulting in
a multiplicity of infection (MOI) as indicated. Bacterial superna-
tants were prepared by growing bacteria in 5 ml of brain-heart
infusion (BHI) broth (Merck) in a rotary shaker (160 rpm) at 37uC
for 12–14 h and pelleted for 10 min at 3350 g. Supernatants were
sterile-filtered through a Millex-GP filter unit (0.22 mm; Millipore)
and used for the experiments. For PVL isolation, E. coli TG1
strains containing expression vectors for lukF-PV and lukS-PV
were grown in Luria Bertani (LB)-media with IPTG (1 mM) and
ampicillin (100 mg/ml) and cell lysates were used to purify PVL
(Figure S1A).
Plasmid construction and transformation
Different genes were amplified by PCR using chromosomal
DNA from different strains (Table S1) as template. To create S.
carnosus strains, which express virulence factors of S. aureus, we used
two basic vectors, the xylose inducible pXR100 and the
pNXR100, which is a non-inducible derivate of the pXR100.
For the expression of lukF-PV and lukS-PV in E. coli TG1 the
commercial IPTG inducible pQE30UA was used. For creation of
the expression vectors the respective genes were amplified by
PCR, purified and digested. The basic vectors were also digested
corresponding to the genes. After ligation S. carnosus TM300
and E. coli were transformed by protoplast transformation or
CaCl–method.
Generation of purified staphylococcal virulence factors
and antibodies
The Six-histagged lukF-PV and lukS-PV proteins from E. coli
were purified by nickel-nitrilotriacetic acid affinity resin (Qiagen,
Germany). a-toxin and Protein A (P3838) were obtained from
Sigma-Aldrich Chemie GmbH (Germany). PSMa1 – PSMa3
were synthesized by Genosphere Biotechnology (France). Poly-
clonal antibodies against lukF-PV and lukS-PV were raised
separately and together in rabbits by standard procedures and
this was performed by Genosphere-Biotechnology (France).
Preparation and culture of neutrophils
Human, rabbit and Java monkey polymorphonuclear cells
(neutrophils) were freshly isolated from Na citrate-treated blood of
healthy donors. Neutrophils from BALB/c and C57/BL6 mice
were prepared from bone marrow. For neutrophil-isolation,
dextran-sedimentation and density gradient centrifugation using
Ficoll-Paque Plus (Amersham Bioscience) was used according to
the manufacturer’s instruction. Cell purity was determined by
Giemsa staining and was always above 99%. For murine cells,
sedimented cells were used as neutrophils and, in addition, were
further deprived of CD3
+ (T cells), CD19
+ (B cells), and CD11c
+
(dendritic cells) cells using MACS technology (Miltenyi Biotech,
Bergisch- Gladbach) according to the manufacturer’s instruction.
Resulting cells were ,0.1% CD3
+, CD19
+, or CD11c
+ and ,95%
CD11b
+ and Gr1
+. Neutrophils were resuspended at a final
density of 1610
6 cells/0.5 ml in RPMI 1640 culture medium
(PAA Laboratories GmbH) supplemented with 10% heat-inacti-
vated FCS (PAA Laboratories GmbH) and immediately used for
the experiments. All incubations were performed at 37uCi n
humidified air with 5% CO2.
Cell culture experiments and measurements of oxidative
burst activity and cell death
All experiments were performed in 24-well plates and
neutrophils were incubated with PVL, a-toxin, PSMs, live bacteria
or bacterial supernatants at the indicated concentrations. Oxida-
tive burst activity was determined after 10 min of incubation using
a phagoburst test (Orpegen Pharma) according to the manufac-
turer’s instruction. Measurement of cell death was performed after
1 h of incubation followed by washing and double staining of cells
with annexin V-FITC and propidium iodide (PI) (taking 1 hour)
and then cells were analyzed in a FACScalibur flow cytometer
using an annexin V-FITC apoptosis detection kit (Becton
Dickinson). For analysis of time-dependent cell death inductions,
cells were incubated for the indicated time periods, followed by
washing and single staining with PI (taking 10 min) and then cells
were immediately analysed by flow cytometry.
Light and transmission electron microscopy
A live cell imaging system (Zeiss) was used to obtain light
micrographs. For transmission electron microscopy, 5610
6/2.5 ml
neutrophils were incubated with PVL at the indicated concentra-
tionsfor1 h.ThenthecellswerewashedthreetimeswithPBS,fixed
in 3% glutaraldehyde, stained in 1% osmium tetroxide and
embedded in epoxy resin in the culture dish in situ. Electron
micrographs were obtained using imaging plate technology.
Statistical analysis
Unpaired Student’s t-test was performed to compare cell
survival. A value of P#0.05 was considered significant in all cases.
Supporting Information
Table S1 Vector construction
Found at: doi:10.1371/journal.ppat.1000715.s001 (0.08 MB PDF)
Figure S1 Western-blot and SDS-PAGE analysis of S. aureus
USA300 lukF-PV and lukS-PV and of PVL in bacterial
supernatants of indicated strains. His-Tag lukF and lukS proteins
were expressed in E. coli using pQE30UA and proteins were
purified on NI-NTA resin. After separation by SDS-PAGE,
proteins were visualized by Coomassie blue. For Western-blot
analysis, proteins separated on SDS-page were blotted onto a
nitrocellulose membrane. Detection of PVL (lukF and lukS) was
done with anti-PVL antibodies raised in rabbits followed by
incubation with anti-rabbit alkaline phosphatase conjugated
antibodies and bands were visualized in a color reaction using
avidin alkaline phosphatase. Molecular weight standards are
in kDa (Figure S1A). To detect PVL released in bacterial culture
supernatants, staphylococcal strains were grown in 5 ml of
PVL Kills Human Neutrophils
PLoS Pathogens | www.plospathogens.org 10 January 2010 | Volume 6 | Issue 1 | e1000715brain-heart infusion (BHI), supernatants were sterile-filtered as
described and were used for Western-blot analysis (Figures S1B,
S1C). The amount of PVL was determined semi-quantitatively in
five categories: -, no PVL production; +/-, borderline; +, low; ++,
+++, high and very high PVL production. The results are also
listed in Table 1 and Figure 5.
Found at: doi:10.1371/journal.ppat.1000715.s002 (1.27 MB TIF)
Figure S2 Cell death induced by PVL in neutrophils lacks
apoptotic features. Human neutrophils were freshly isolated and
1610
6 0.5 ml
21 cells were incubated with increasing doses of
purified PVL with or without zVAD-fmk (50 mM) as indicated.
zVAD is a pan-caspase inhibitor (Enzyme Systems), which
inhibited apoptotic cell death induced by a-toxin in mononuclear
cells [33]. After 1 h cells were double-stained with propidium
iodide to detect necrosis-like membrane damage and with annexin
V-fluorescein isothiocyanate to detect apoptotic phosphatidylser-
ine exposure to the cell surface by flow cytometry. Figure S2A
shows the percentage of intact cells and the values represent the
mean 6 SEM of four different experiments. No significant
differences were detected in cells treated with zVAD compared to
cells treated without zVAD. Figure S2B shows one representative
flow cytometric measurement. We could not detect annexin V
positive cells at any dose of PVL tested. These results indicate that
rapid cell death induced by PVL lacks apoptotic features and is
most likely due to necrosis.
Found at: doi:10.1371/journal.ppat.1000715.s003 (2.01 MB TIF)
Figure S3 Murine neutrophils are largely resistant to PVL
irrespective of their maturation and inflammatory state. In Figure
S3A neutrophils from BALB/c mice were isolated from bone
marrow or were analysed by flow cytometry (gating) in whole
peripheral blood, as indicated. Cells were stimulated with lukS-PV
or with lukF-PV or with both components (PVL: 4 mg/ml) for
90 min. After stimulation cells were stained with annexin V and
propidium iodide and then the rate of cell death was measured by
flow cytometry. In Figure S3B neutrophils from BALB/c mice
(control mice, stess-induced mice or S. aureus-infected mice) were
isolated from bone marrow. For stress-induction mice were fixed
(immobilized) for 30 min/day on 4 consecutive days. It has been
shown that fixation leads to stress induction that can be measured
by increased levels of glucocorticoids in the serum [34]. For S.
aureus infection mice were infected with S. aureus SH1000 (2610
7
bacteria) into the footpad 7 days before cell isolation. For the
experiments, 1610
6 cells were stimulated with PVL (4 mg/ml) for
90 min. After stimulation cells were stained with annexin V and
propidium iodide and then the rate of cell death was measured by
flow cytometry.
Found at: doi:10.1371/journal.ppat.1000715.s004 (1.19 MB
TIF)
Figure S4 Low doses of PVL induce proinflammatory activation
of human neutrophils. Human neutrophils were freshly isolated
and 1610
6cells were stimulated with different doses of PVL (4 -
400 ng/ml) for 60 min. After stimulation RNA was isolated from
the cells and expression of selected genes was confirmed by real-
time reverse transcription-polymerase chain reaction (RT-PCR).
The primers used for PCR analysis were as follows: IL-1b forward,
59-GCGGCCAGGATATAACTGACTTC-39; IL-1b reverse, 59-
GCGGCCAGGATATAACTGACTTC-39-TCCACATTCAG-
CACAGGACTCTC-39-GCGGCCAGGATATAACTGACTTC-
39; IL-8 forward, 59-GCGGCCAGGATATAACTGACTTC-39-
CTTGTTCCACTGTGCCTTGGTT-39-GCGGCCAGGATA-
TAACTGACTTC-39; IL-8 reverse, 59-GCGGCCAGGATATA-
ACTGACTTC-39-GCTTCCACATGTCCTCACAACAT-39-G-
CGGCCAGGATATAACTGACTTC-39; GAPDH forward, 59-G-
CGGCCAGGATATAACTGACTTC-39-TGCACCACCAACTG
CTTAGC-39-GCGGCCAGGATATAACTGACTTC-39 ; GAPDH
reverse, 59-GCGGCCAGGATATAACTGACTTC-39-GGCAT-
GGACTGTGGTCATGAG-39-GCGGCCAGGATATAACTG-
ACTTC-39; RPL forward, 59-GCGGCCAGGATATAACTGA-
CTTC-39-AGGT ATGCTGCCCCACAAAAC-39-GCGGCCA-
GGATATAACTGACTTC-39; RPL reverse, 59-GCGGCCAG-
GATATAACTGACTTC-39-TGTAGGCTTCAGACGCACGAC-
39-GCGGCCAGGATATAACTGACTTC-39. The relative expres-
sion was calculated as 2
DCt
specific gene /2
DCt
mean (houskeeping gene),
using glyceraldehyde phosphate dehydrogenase (GAPDH) and
ribosomal protein L13a (RPL), as endogenous housekeeping
control genes (A and B). The culture supernatants of the
stimulated cells were collected after 6 h and 16 h and the protein
levels of IL-1b were determined by ELISA (Becton Dickinson)
according to the manufacturer’s instructions (C). The values
represent the means 6SD of three independent experiments.
Similar experiments were performed with murine neutrophils
from BALB/c mice, but here no induction of murine chemokine
KC expression could be detected (data not shown).
Found at: doi:10.1371/journal.ppat.1000715.s005 (0.64 MB
TIF)
Figure S5 Antibodies against PVL cannot prevent the cytotoxic
effect of the PVL-expressing strain USA300. Human neutrophils
were freshly isolated and 1610
6 0.5 ml
21 cells were incubated
with purified PVL (80 ng/ml), with live bacteria (MOI 50) of the
PVL-expressing strain USA300 or of the wild-type isolate ST239,
which lacks the gene for PVL. In bacterial supernatants protein A
was removed to avoid unspecific binding of antibodies to protein
A. Antibodies against PVL (15 mg/ml) were added to the cells
before cells were incubated with PVL, live bacteria. Co-incubation
with antibodies completely prevented the effect of purified PVL,
whereas control antibodies (against extracellular matrix protein
Emp) had no effect. The effect of strain USA300 was not affected
by the addition of antibodies against PVL and was similar to the
action of wild-type strain ST 239. These results suggest that S.
aureus wild-type isolates express a multitude of virulence factors,
which promote cell death induction. However, as cell death of
neutrophils is part of the immediate immune response following
exposure to pathogens and/or phagocytosis of bacteria, the action
of secreted PVL from USA300 might be masked in this model. ***
P#0.001 comparing the rate of intact cells between control and
stimulated cells.
Found at: doi:10.1371/journal.ppat.1000715.s006 (0.08 MB TIF)
Figure S6 Bacterial supernatants from TM300+PSMs induce
neutrophil lysis. Human neutrophils were freshly isolated and
1610
6 0.5 ml
21 cells were incubated with bacterial supernatants of
the strains TM300 and TM300+PSMs. Bacterial supernatants
were prepared from bacteria grown in brain-heart infusion broth
in a rotatory shaker for 40 h and supernatants were sterile filtered
and added to the cell culture medium at a final concentration of
30%. The values represent the mean 6 SEM of three independent
experiments. ** P#0.01 comparing the rate of intact cells between
control and stimulated cells. Supernatants from the parent strain
TM300 did not affect cell viability, whereas supernatants from
strain TM300+PSMs induced cell lysis. As live bacteria from
TM300+PSMs did not induce cell death (Figure 3A), these results
indicate that PSMs have to accumulate in the bacterial
supernatants to reach sufficient high concentrations to induce cell
lysis.
Found at: doi:10.1371/journal.ppat.1000715.s007 (0.07 MB TIF)
Figure S7 S. carnosus TM300, which heterologously expresses
covalently bound surface proteins, induce apoptotic cell death in
PVL Kills Human Neutrophils
PLoS Pathogens | www.plospathogens.org 11 January 2010 | Volume 6 | Issue 1 | e1000715human neutrophils. Human neutrophils were freshly isolated and
1610
6 0.5 ml
21 cells were incubated with live bacteria of S.
carnosus strains expressing protein A or FnBPs at an MOI of 200.
After 1 h of incubation cells were washed, stained with annexin V
and propidium iodide (taking another hour) and then cell death
was measured by flow cytometry. This figure shows one
representative flow cytometric measurement. Here, we could
detect a clear shift towards annexin V positive cells (positive for
annexin V and negative for PI: sign for early apoptosis) resulting in
15–20% apoptotic cells. By contrast, stimulation with PVL did not
cause apoptotic features (see Figure S2). These results indicate that
strains, which express virulent surface proteins, can induce forms
of programmed cell death.
Found at: doi:10.1371/journal.ppat.1000715.s008 (1.79 MB TIF)
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